Fresh Equities
ASX:BDA

ASX:BDA

BOD AUSTRALIA LIMITED

BOD AUSTRALIA LIMITED has not announced any current capital raises, but we are collecting interest for future raises.

Demand Registered for Next Raise
< $50k
Investors Interested in Next Raise
< 10
How Fresh Equities Works
Authentication

1. Create Account

Complete your onboarding digitally in less than 3 minutes.

Authentication

2. View Terms

View the full term sheet for the capital raise.

Authentication

3. Bid for Allocation

Submit and track your bid online.

Capital Raise History

Loading...


Company Overview

Bod Australia Limited (BDA) is a marketer and distributor of brands in the beauty and personal care industry and distributes skin care and health products throughout Australia. Bod Australia operates under exclusive distribution agreement for Dr Roebuck's and BIOEFFECT brand. Company's major objectives is to develop a portfolio of proprietary health products.

Type

Listed Company

GICS Sub-industry

Distributors

Head Office

Level 1/377 New South Head Rd, Double Bay NSW 2028, Australia

Distributors
Consumer Discretionary
Consumer

Price Chart


Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.

Loading...


Directors


Announcements

All
All Time
  • Swisse Wellness and Bod launch first hemp products on 29 March 2020

    Progress Report

  • Half yearly financial statements and Appendix 4D on 27 February 2020

    Periodic Reports

  • Bod's medicinal cannabis sales off to strong start in CY2020 on 17 February 2020

    Progress Report

  • Managing Director audio interview on 13 February 2020

    Progress Report

  • Import permit received to expand medicinal cannabis products on 10 February 2020

    Progress Report

  • Quarterly Activities Report and Appendix 4C on 27 January 2020

    Commitments test entity quarterly reports

  • Change of Director's Interest and Final Director's Interest on 19 December 2019

    Shareholder Details

    Resignation of Alternate Director on 18 December 2019

    Company Administration

  • Bod and H&H Group launch first CBD products in the UK on 15 December 2019

    Progress Report

  • Bod enters research collaboration with UniSA on 11 December 2019

    Progress Report

  • Load More

News

Loading...